Sensipar — CareFirst (Caremark)
Primary hyperparathyroidism in adult patients unable to undergo parathyroidectomy
Initial criteria
- Member is not able to undergo parathyroidectomy
- Serum calcium level (corrected for albumin) ≥ 8.4 mg/dL
Reauthorization criteria
- Member is experiencing benefit from therapy (e.g., decreased or normalized corrected serum calcium levels since starting therapy)
Approval duration
12 months